Sartorius Stedim Biotech’s stock has rebounded to €159.40, up 2.51%, after previously hitting a low of €153 following a disappointing quarterly report. The company reported a slight revenue increase of 7.9% but faced a marginal decline in EBITDA margins to 30.7%. Despite today’s gains, the stock remains below its moving averages, indicating a bearish trend. Investor attention is now turning to the upcoming half-yearly results set for July 23. The CAC 40 index is also up by 0.47% during this trading session.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.ideal-investisseur.fr/en/actions-b/sartorius-stedim-biotech-shares-rebound-above-eur159-exiting-oversold-territory/18733.html
